121 related articles for article (PubMed ID: 37231813)
21. ciRS-7 Promotes the Proliferation and Migration of Papillary Thyroid Cancer by Negatively Regulating the miR-7/Epidermal Growth Factor Receptor Axis.
Han JY; Guo S; Wei N; Xue R; Li W; Dong G; Li J; Tian X; Chen C; Qiu S; Wang T; Xiao Q; Liu C; Xu J; Chen KS
Biomed Res Int; 2020; 2020():9875636. PubMed ID: 32685551
[TBL] [Abstract][Full Text] [Related]
22. MiR-506 suppresses papillary thyroid carcinoma cell proliferation and metastasis via targeting IL17RD.
Zhu J; Zhang Q; Jin XY; Cai JB; Chen X; Shi WB; Pang WY; Guo GL; Yang LJ
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2856-2862. PubMed ID: 31002136
[TBL] [Abstract][Full Text] [Related]
23. RETRACTED: MicroRNA-361-5p inhibits papillary thyroid carcinoma progression by targeting ROCK1.
Li R; Dong B; Wang Z; Jiang T; Chen G
Biomed Pharmacother; 2018 Jun; 102():988-995. PubMed ID: 29710554
[TBL] [Abstract][Full Text] [Related]
24. Changes of serum miR-221 and miR-145 levels with papillary thyroid carcinoma and their relationship with invasive activity.
Zhu ZC; Li T; Yao TQ; Bi JC; Jiao LH
Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(5):293-301. PubMed ID: 35818240
[TBL] [Abstract][Full Text] [Related]
25. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma.
Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y
Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818
[TBL] [Abstract][Full Text] [Related]
26. MiR-200c promotes papillary thyroid cancer cell proliferation, migration, and invasion by downregulating PTEN.
Guo K; Wang J; Shu L; Zhou G
Tissue Cell; 2021 Dec; 73():101647. PubMed ID: 34543800
[TBL] [Abstract][Full Text] [Related]
27. circRPS28 (hsa_circ_0049055) is a novel contributor for papillary thyroid carcinoma by regulating cell growth and motility via functioning as ceRNA for miR-345-5p to regulate frizzled family receptor 8 (FZD8).
Mao Y; Huo Y; Li J; Zhao Y; Wang Y; Sun L; Kang Z
Endocr J; 2021 Nov; 68(11):1267-1281. PubMed ID: 34108309
[TBL] [Abstract][Full Text] [Related]
28. MiR-141-3p Suppresses Tumor Growth and Metastasis in Papillary Thyroid Cancer via Targeting Yin Yang 1.
Fang M; Huang W; Wu X; Gao Y; Ou J; Zhang X; Li Y
Anat Rec (Hoboken); 2019 Feb; 302(2):258-268. PubMed ID: 30290400
[TBL] [Abstract][Full Text] [Related]
29. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of miR-519d-3p is Associated with Poor Outcomes and Facilitates Tumor Progression in Papillary Thyroid Cancer by Regulating FOXQ1.
Li P; Pan X; Zheng Z; Sun Y; Han Y; Dong J; Lu M
Horm Metab Res; 2021 Sep; 53(9):625-632. PubMed ID: 34496413
[TBL] [Abstract][Full Text] [Related]
31. Circ_PSD3 promotes the progression of papillary thyroid carcinoma via the miR-637/HEMGN axis.
Li Z; Huang X; Liu A; Xu J; Lai J; Guan H; Ma J
Life Sci; 2021 Jan; 264():118622. PubMed ID: 33203523
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma.
Wang Z; Zhang H; Zhang P; Dong W; He L
Tumour Biol; 2016 Jun; 37(6):7633-44. PubMed ID: 26687649
[TBL] [Abstract][Full Text] [Related]
33. MiR-30c-5p loss-induced PELI1 accumulation regulates cell proliferation and migration via activating PI3K/AKT pathway in papillary thyroid carcinoma.
Zheng T; Zhou Y; Xu X; Qi X; Liu J; Pu Y; Zhang S; Gao X; Luo X; Li M; Wang X; Dong L; Wang Y; Mao C
J Transl Med; 2022 Jan; 20(1):20. PubMed ID: 34991623
[TBL] [Abstract][Full Text] [Related]
34. MiR-203a-3p, miR-204-3p, miR-222-3p as useful diagnostic and prognostic tool for thyroid neoplasia spectrum.
Stojanović S; Dobrijević Z; Šelemetjev S; Đorić I; Janković Miljuš J; Živaljević V; Išić Denčić T
Endocrine; 2023 Jan; 79(1):98-112. PubMed ID: 36103016
[TBL] [Abstract][Full Text] [Related]
35. A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.
Feng J; Zhou Q; Yi H; Ma S; Li D; Xu Y; Wang J; Yin S
Cell Death Dis; 2019 Jun; 10(6):433. PubMed ID: 31160577
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
[TBL] [Abstract][Full Text] [Related]
37. LINC00958/miR-627 signal axis regulates the proliferation, migration, and invasion of thyroid papillary carcinoma cells by TRIM44.
Li YQ; Wang LC; Li AX; Huang W; Song Y; Wang W
Kaohsiung J Med Sci; 2022 May; 38(5):415-424. PubMed ID: 35199939
[TBL] [Abstract][Full Text] [Related]
38. LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling.
Wang X; Lu X; Geng Z; Yang G; Shi Y
J Cell Biochem; 2017 Dec; 118(12):4745-4752. PubMed ID: 28513866
[TBL] [Abstract][Full Text] [Related]
39. microRNA-124-3p inhibits tumourigenesis by targeting mitogen-activated protein kinase 4 in papillary thyroid carcinoma.
Sun Y; Zhang L; Zhang S
Cell Biochem Funct; 2020 Dec; 38(8):1017-1024. PubMed ID: 32495394
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer.
Gao H; Sun X; Wang H; Zheng Y
Cell Cycle; 2020 May; 19(10):1186-1199. PubMed ID: 32306838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]